Skip to main content

BPC-157 & TB-500 (Wolverine Stack) vs Substance P

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BPC-157 & TB-500 (Wolverine Stack)

Known as the 'Wolverine Stack,' this popular combination pairs two powerful healing peptides. BPC-157 and TB-500 work synergistically to promote tissue repair, reduce inflammation, and accelerate recovery from injuries.

Full details →

Substance P

Substance P is an 11-amino acid neuropeptide involved in pain transmission, inflammation, and various neurological processes. While not used therapeutically itself, understanding it is crucial for pain research.

Full details →

Side-by-Side Comparison

AspectBPC-157 & TB-500 (Wolverine Stack)Substance P
MechanismBPC-157 upregulates growth factor expression and promotes angiogenesis, while TB-500 promotes cell migration and differentiation through actin regulation. Together, they enhance wound healing, reduce scar tissue formation, and support musculoskeletal recovery through complementary pathways.Binds primarily to NK1 receptors to transmit pain signals from peripheral nerves to the CNS. Also promotes inflammation, causes vasodilation, and stimulates immune cells.
Typical DosageTypical research protocols: BPC-157 at 250-500mcg daily combined with TB-500 at 2-2.5mg twice weekly during loading phase, then 2mg every 2 weeks for maintenance.Not used as a therapeutic agent. NK1 receptor antagonists (blocking Substance P) are used clinically for chemotherapy-induced nausea.
AdministrationBoth peptides administered via subcutaneous injection. Some protocols suggest injecting near injury sites for localized effects. Can be injected separately or as a pre-mixed blend.Research compound only. Therapeutic applications focus on blocking rather than administering Substance P.
Side EffectsGenerally well-tolerated. May include mild nausea, temporary fatigue, headache, or localized irritation at injection sites.Administration would cause pain, inflammation, and neurogenic responses. Not given therapeutically.
Best For

Key Differences

Unique to BPC-157 & TB-500 (Wolverine Stack):

Unique to Substance P:

Ready to Learn More?